BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.
BTIG Downgrades Applied Genetic to Neutral
BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.
Related Posts
Why Stocks Are Trading Slightly Lower; U.S. Manufacturing PMI Slips
U.S. stocks traded slightly lower this morning, after recording gains in the previous session.
How Canopy Growth Reduced Debt By $1B And Is Headed Toward Profitability With An ‘Asset-Light Model’: CEO Tells All
As cannabis earnings rolled in all week, Canopy Growth Corp (NASDAQ: CGC) held its own, reporting quarterly sales of CA$109 million ($81.2 million), which beat the analyst consensus estimate of CA$67.98 million, a 26.32% increase over sales of CA$86.29 million the same period last year.
Analyst Ratings for The Chefs’ Warehouse
Within the last quarter, The Chefs' Warehouse (NASDAQ:CHEF) has observed the following analyst ratings: